RecruitingEarly Phase 1NCT07239895

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Regend Therapeutics
Intervention
Airway Basal Stem Cells(biological)
Enrollment
12 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

Shanghai Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07239895 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials